Login / Signup

Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm.

Matthew SchwedeIrena T TanDanielle F AtibalentjaMeghan M DickmanKerri E RiegerGabriel N Mannis
Published in: Annals of hematology (2020)
Keyphrases
  • dendritic cells
  • combination therapy
  • chronic lymphocytic leukemia
  • low grade
  • regulatory t cells
  • immune response
  • open label
  • randomized controlled trial
  • clinical trial
  • double blind